Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 3/20 | 0.50 |
| ▸ | CASP1 | P29466 | 7/20 | 0.47 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.45 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.45 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.45 |
| ▸ | LGMN | Q99538 | 1/20 | 0.45 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.45 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.45 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1264575 | 0.93 | CASP3 (0.55) | CTSKCASP1CASP3 | |
| SCHEMBL29453232 | 0.84 | MME (0.58) | CTSKCASP1PSMB5PSMB8PSMB9 | |
| SCHEMBL7155003 | 0.83 | MME (0.59) | CTSKCASP1PSMB5PSMB8PSMB9 | |
| SCHEMBL4430771 | 0.83 | MME (0.59) | CTSKCASP1PSMB5PSMB8PSMB9 | |
| SCHEMBL14433707 | 0.83 | MME (0.59) | CTSKCASP1PSMB5PSMB8PSMB9 | |
| SCHEMBL29825423 | 0.83 | CASP3 (0.60) | CTSKCASP1CASP3 | |
| SCHEMBL10868042 | 0.82 | CAPN1 (0.58) | CTSKCASP1 | |
| SCHEMBL17841948 | 0.82 | CTSK (0.56) | CTSKCASP1PSMB5PSMB8PSMB9 | |
| SCHEMBL28840715 | 0.82 | CASP3 (0.55) | CTSKCASP1CASP3 | |
| SCHEMBL811863 | 0.82 | CASP3 (0.55) | CTSKCASP1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090325168-A1 | HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES | ONCOIMMUNIN, INC. (US) | 2009-12-31 | — | — | US | disclosed |
| EP-0988394-B1 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN INC (US) | 2009-12-30 | — | — | EP | disclosed |
| US-7541143-B2 | Homo-doubly labeled compositions for the detection of enzyme activity in biological samples | ONCOIMMUNIN, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| EP-1214445-A4 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN INC (US) | 2007-01-24 | — | — | EP | disclosed |
| US-6936687-B1 | Compositions for the detection of enzyme activity in biological samples and methods of use thereof | ONCO IMMUNIN, INC. (US) | 2005-08-30 | — | — | US | disclosed |
| US-20050158766-A1 | Homo-doubly labeled compositions for the detection of enzyme activity in biological samples | ONCOLMMUNIN, INC. | 2005-07-21 | — | — | US | disclosed |
| US-6893868-B2 | Homo-doubly labeled compositions for the detection of enzyme activity in biological samples | ONCO IMMUNIN, INC. (US) | 2005-05-17 | — | — | US | disclosed |
| US-20030207264-A1 | Homo-doubly labeled compositions for the detection of enzyme activity in biological samples | ONCOLMMUNIN, INC. | 2003-11-06 | — | — | US | disclosed |
| EP-1356084-A2 | HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES | ONCOIMMUNIN, INC. (US) | 2003-10-29 | — | — | EP | disclosed |
| EP-0988394-A4 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN INC (US) | 2003-04-23 | — | — | EP | disclosed |
| WO-2002061038-A9 | HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES | ONCOIMMUNIN INC (US) | 2002-11-28 | — | — | WO | disclosed |
| WO-2002061038-A2 | HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES | ONCOIMMUNIN, INC. (US) | 2002-08-08 | — | — | WO | disclosed |
| EP-1214445-A1 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN, INC. (US) | 2002-06-19 | — | — | EP | disclosed |
| WO-2001018238-A1 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN, INC. (US) | 2001-03-15 | — | — | WO | disclosed |
| EP-0988394-A1 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN, INC. (US) | 2000-03-29 | — | — | EP | disclosed |
| US-6037137-A | FLUORESCENT COMPOUND FOR SCREENING CLEAVING ACTIVITY AND STRUCTURAL CHANGES OF ENZYMATIC PROTEINS | ONCOIMMUNIN, INC. (US) | 2000-03-14 | — | — | US | disclosed |
| WO-1998037226-A1 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN, INC. (US) | 1998-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207264-A1 | Homo-doubly labeled compositions for the detection of enzyme activity in biological samples | DNTT, HMBS, WRN | CTSK 534/4885CASP1 1731/4885PSMB5 2102/4885 |
| US-20050158766-A1 | Homo-doubly labeled compositions for the detection of enzyme activity in biological samples | DNTT, WRN, HMBS | CTSK 519/4885CASP1 1504/4885PSMB5 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.